Last updated on 21 Sept 2021
Owner Info
Revance Therapeutics, Inc.
7555 Gateway Blvd.
Newark CA 94560, UNITED STATES OF AMERICA
Serial Number
2191160 filed on 16 Apr 2021
Correspondent
Maren C. Perry King & Spalding LLP
1185 Avenue of the Americas,
New York NY 10036,
UNITED STATES OF AMERICA
2191160
16 Apr 2021
16 Apr 2031
FIGURATIVE
19 Oct 2020
US
Status Date | Action Taken |
---|---|
21st Sept 2021 | International Registration in Australia Protected correspondence sent |
20th Sept 2021 | IP Right Registration Published |
20th Sept 2021 | Status change to Registered/Protected |
14th Jul 2021 | Application Accepted correspondence sent |
13th Jul 2021 | IP Right has been Examined |
13th Jul 2021 | IP Right Acceptance Published |
13th Jul 2021 | Status change to Accepted |
8th Jul 2021 | Examination expedited |
8th Jul 2021 | Awaiting examination |
8th Jul 2021 | Word and image indexing completed |